Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications for Bioengineering Research Grants Sought

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) invites applications to support bioengineering research grants (BRGs). This announcement is made together with 19 other components of the National Institutes of Health (NIH).*

BRGs support multi-disciplinary research-performed in a single laboratory or by a small number of investigators-that applies an integrative, systems approach to develop knowledge and methods to prevent, detect, diagnose, and treat disease, and to understand health and behavior. Many of today's biomedical problems are best addressed using a multi-disciplinary approach that extends beyond traditional biological and clinical science. Bioengineering integrates principles from a diversity of fields-crossing the boundaries of academia, science, medicine, and industry.

Applications for BRGs should focus on areas of basic, applied, behavioral, or clinical research in bioengineering that supports the missions of the NIH institutes and centers and where progress is likely to make a significant contribution to improving human health.

For more information, potential applicants should contact Repair and Plasticity Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2207, Bethesda, MD 20892; telephone: 301-496-1447; fax: 301-402-1080; e-mail: funding@ninds.nih.gov.

*For a full list of supporting NIH components and a more detailed description of this program announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PA-02-011.html.